ICCM fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ICCM has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company